PURPOSE: Tear turnover rate (TTR) is defined as the percent decrease of fluorescein concentration in the tears per minute after the instillation of fluorescein. The purpose of this study was to examine differences in TTR in a sample with symptoms of dry eye and an asymptomatic control sample using the Fluorotron Master Fluorophotometer. METHODS: TTR was measured using the OcuMetrics Fluorotron Master. It measures the decay of the fluorescence of high molecular weight fluorescein FITC Dextran instilled into the tear film. Twenty participants (post-menopausal women) were enrolled in the study (10 asymptomatic (age 64.7 +/- 6.99) and 10 symptomatic (age 61.5 +/- 7.98)). Participants were grouped according to either a positive (symptomatic) or negative (asymptomatic) McMonnies Dry Eye Questionnaire, i.e., an indication of self-reported ocular dryness and the use of rewetting/lubricating drops (questions 4 and 5). TTR was measured in the afternoon only. Measurements were made on the right eye with a controlled blink rate (15 blinks/min), for up to 30 min, post-insertion of 2 microl of 2% FITC Dextran (MW 9500). The scan data were used to construct a graph of log fluorescein concentration (ng/ml) as a function of time and the TTR calculated (%/ min = (1- ln (slope)) x 100). RESULTS: There was a significant difference in the TTR between symptomatic and asymptomatic subjects. Mean TTR (symptomatic) was 4.89 +/-2.74%/min (range, 2.04-11.81) and mean TTR (asymptomatic) was 11.85 +/- 3.31%/min (range, 5.76-16.45) (P < 0.0001). CONCLUSIONS: Fluorophotometry may be used to demonstrate differences in the tear turnover rate in this post-menopausal group of women, with patients experiencing symptoms of dry eye having a lower TTR than the normals.
PURPOSE: Tear turnover rate (TTR) is defined as the percent decrease of fluorescein concentration in the tears per minute after the instillation of fluorescein. The purpose of this study was to examine differences in TTR in a sample with symptoms of dry eye and an asymptomatic control sample using the Fluorotron Master Fluorophotometer. METHODS: TTR was measured using the OcuMetrics Fluorotron Master. It measures the decay of the fluorescence of high molecular weight fluorescein FITC Dextran instilled into the tear film. Twenty participants (post-menopausal women) were enrolled in the study (10 asymptomatic (age 64.7 +/- 6.99) and 10 symptomatic (age 61.5 +/- 7.98)). Participants were grouped according to either a positive (symptomatic) or negative (asymptomatic) McMonnies Dry Eye Questionnaire, i.e., an indication of self-reported ocular dryness and the use of rewetting/lubricating drops (questions 4 and 5). TTR was measured in the afternoon only. Measurements were made on the right eye with a controlled blink rate (15 blinks/min), for up to 30 min, post-insertion of 2 microl of 2% FITC Dextran (MW 9500). The scan data were used to construct a graph of log fluorescein concentration (ng/ml) as a function of time and the TTR calculated (%/ min = (1- ln (slope)) x 100). RESULTS: There was a significant difference in the TTR between symptomatic and asymptomatic subjects. Mean TTR (symptomatic) was 4.89 +/-2.74%/min (range, 2.04-11.81) and mean TTR (asymptomatic) was 11.85 +/- 3.31%/min (range, 5.76-16.45) (P < 0.0001). CONCLUSIONS: Fluorophotometry may be used to demonstrate differences in the tear turnover rate in this post-menopausal group of women, with patients experiencing symptoms of dry eye having a lower TTR than the normals.
Authors: Richard J Braun; Nicholas R Gewecke; Carolyn G Begley; P Ewen King-Smith; Javed I Siddique Journal: Invest Ophthalmol Vis Sci Date: 2014-02-26 Impact factor: 4.799
Authors: Kyung-Chul Yoon; Cintia S De Paiva; Hong Qi; Zhuo Chen; William J Farley; De-Quan Li; Michael E Stern; Stephen C Pflugfelder Journal: J Autoimmun Date: 2007-11-07 Impact factor: 7.094
Authors: Kelsea V Skidmore; Maria K Walker; Jason D Marsack; Jan P G Bergmanson; William L Miller Journal: Cont Lens Anterior Eye Date: 2018-11-16 Impact factor: 3.077
Authors: Essam A Tawfik; Mariagiovanna Scarpa; Hend E Abdelhakim; Haitham A Bukhary; Duncan Q M Craig; Susan A Barker; Mine Orlu Journal: Pharmaceutics Date: 2021-01-19 Impact factor: 6.321
Authors: Ruti Sella; Yamit Cohen-Tayar; Takako Noguchi; Emma N Finburgh; Rebecca R Lian; Anser A Abbas; Dominic F Hakim; Jennifer J Bu; Jiagang Zhao; Peter Shaw; Irit Bahar; Natalie A Afshari Journal: Transl Vis Sci Technol Date: 2022-09-01 Impact factor: 3.048
Authors: Lionel Sebbag; Rachel A Allbaugh; Rita F Wehrman; Lisa K Uhl; Gil Ben-Shlomo; Thomas Chen; Jonathan P Mochel Journal: J Ocul Pharmacol Ther Date: 2019-08-08 Impact factor: 2.671